Publication | Open Access
Sensitized mutagenesis screen in Factor V Leiden mice identifies thrombosis suppressor loci
20
Citations
43
References
2017
Year
Factor V Leiden (<i>F5</i><sup><i>L</i></sup> ) is a common genetic risk factor for venous thromboembolism in humans. We conducted a sensitized <i>N</i>-ethyl-<i>N</i>-nitrosourea (ENU) mutagenesis screen for dominant thrombosuppressor genes based on perinatal lethal thrombosis in mice homozygous for <i>F5</i><sup><i>L</i></sup> (<i>F5</i><sup><i>L/L</i></sup> ) and haploinsufficient for tissue factor pathway inhibitor (<i>Tfpi</i><sup><i>+/-</i></sup> ). <i>F8</i> deficiency enhanced the survival of <i>F5</i><sup><i>L/L</i></sup><i>Tfpi</i><sup><i>+/-</i></sup> mice, demonstrating that <i>F5</i><sup><i>L/L</i></sup><i>Tfpi</i><sup><i>+/-</i></sup> lethality is genetically suppressible. ENU-mutagenized <i>F5</i><sup><i>L/L</i></sup> males and <i>F5</i><sup><i>L/+</i></sup><i>Tfpi</i><sup><i>+/-</i></sup> females were crossed to generate 6,729 progeny, with 98 <i>F5</i><sup><i>L/L</i></sup><i>Tfpi</i><sup><i>+/-</i></sup> offspring surviving until weaning. Sixteen lines, referred to as "modifier of Factor 5 Leiden (<i>MF5L1-16</i>)," exhibited transmission of a putative thrombosuppressor to subsequent generations. Linkage analysis in <i>MF5L6</i> identified a chromosome 3 locus containing the tissue factor gene (<i>F3</i>). Although no ENU-induced <i>F3</i> mutation was identified, haploinsufficiency for <i>F3</i> (<i>F3</i><sup><i>+/-</i></sup> ) suppressed <i>F5</i><sup><i>L/L</i></sup><i>Tfpi</i><sup><i>+/-</i></sup> lethality. Whole-exome sequencing in <i>MF5L12</i> identified an <i>Actr2</i> gene point mutation (p.R258G) as the sole candidate. Inheritance of this variant is associated with suppression of <i>F5</i><sup><i>L/L</i></sup><i>Tfpi</i><sup><i>+/-</i></sup> lethality (<i>P</i> = 1.7 × 10<sup>-6</sup>), suggesting that <i>Actr2</i><sup>p.R258G</sup> is thrombosuppressive. CRISPR/Cas9 experiments to generate an independent <i>Actr2</i> knockin/knockout demonstrated that <i>Actr2</i> haploinsufficiency is lethal, supporting a hypomorphic or gain-of-function mechanism of action for <i>Actr2</i><sup>p.R258G</sup> Our findings identify <i>F8</i> and the <i>Tfpi/F3</i> axis as key regulators in determining thrombosis balance in the setting of <i>F5</i><sup><i>L</i></sup> and also suggest a role for <i>Actr2</i> in this process.
| Year | Citations | |
|---|---|---|
Page 1
Page 1